Search
for
Sort by
Research 781–810 of 1000+
- Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the Alopecia + Me study
- Serum interleukin-37 and its gene polymorphism (rs3811047) in Egyptian patients with alopecia areata
- Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Review and Meta-Analysis.
- Evaluation of platelet-rich plasma on hair regrowth and lesional T-cell cytokine expression in alopecia areata: A randomized observer-blinded, placebo-controlled, split-head pilot study
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Therapeutic Approach to Alopecia Areata
- Unveiling the Effect of Age and IgE Level on Alopecia Areata: Insights from Comparative RNAseq Analysis
- Hair Diseases (Alopecia Areata and Androgenetic Alopecia)
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- Lymphocytes, neuropeptides, and genes involved in alopecia areata
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Time to loss of response for dupilumab in ophiasis-pattern alopecia areata
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- The Association Between Alopecia Areata and Iron Deficiency Anemia: A Large-Scale Population-Based Case–Control Study
- Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Autoimmunity: Alopecia Areata
- Cephalalgic Alopecia Areata
- Psychosocial impact of alopecia areata in paediatric and adolescent populations: A systematic review
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Case report of novel combination of anthralin and calcipotriene leading to trichologic response in alopecia areata
- Clinical Presentations and Comorbidities of Pediatric Alopecia Areata
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Trichoscopy pattern in alopecia areata: A systematic review and meta‐analysis
- Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study
- Skin
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3